{"title":"Lossos C, Brown J, Sheikhbahaei S, et al. 特发性多中心 Castleman 病 - TAFRO 导致高水平的 mTOR 激活剂 SVEP1、组织因子和内皮细胞病变。血管血栓止血。2024;1(2):100006.","authors":"","doi":"10.1016/j.bvth.2024.100033","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":100190,"journal":{"name":"Blood Vessels, Thrombosis & Hemostasis","volume":"1 4","pages":"Article 100033"},"PeriodicalIF":0.0000,"publicationDate":"2024-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Lossos C, Brown J, Sheikhbahaei S, et al. Idiopathic multicentric Castleman disease - TAFRO results in high levels of mTOR activator SVEP1, tissue factor, and endotheliopathy. Blood Vessels Thromb Hemost. 2024;1(2):100006.\",\"authors\":\"\",\"doi\":\"10.1016/j.bvth.2024.100033\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":100190,\"journal\":{\"name\":\"Blood Vessels, Thrombosis & Hemostasis\",\"volume\":\"1 4\",\"pages\":\"Article 100033\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Blood Vessels, Thrombosis & Hemostasis\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2950327224000330\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Vessels, Thrombosis & Hemostasis","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950327224000330","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0